NAD+ IV Therapy + Cryotherapy
Documented synergy between NAD+ IV Therapy and Cryotherapy. Canonical combination in literature · see protocol and evidence.
View comparison →Restore cellular energy and slow the ageing process
Definition and how it works: NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme present in every cell, vital for energy production (ATP), DNA repair, and sirtuin regulation. NAD+ IV therapy delivers this coenzyme directly into the bloodstream, achieving plasma levels impossible to reach with oral supplementation. NAD+ levels decline by up to 50% between the ages of 40 and 60 — a process directly linked to ageing.
NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme present in every cell, vital for energy production (ATP), DNA repair, and sirtuin regulation. NAD+ IV therapy delivers this coenzyme directly into the bloodstream, achieving plasma levels impossible to reach with oral supplementation. NAD+ levels decline by up to 50% between the ages of 40 and 60 — a process directly linked to ageing.
Origin and history
NAD+ was discovered by Harden and Young in 1906. Its central role in longevity was revealed by research at MIT and Harvard between 2013 and 2020, sparking a global boom in longevity clinics.
1. Baseline blood work Plasma NAD+ measurement, liver and kidney function tests before starting.
2. Venous access Peripheral IV cannulation. Drip started at a low rate (10 mg/min).
3. Progressive infusion Dose of 250–1,000 mg over 1.5–4 hours. Rate adjusted based on tolerance.
4. Monitoring Heart rate, blood pressure and symptom checks. Medical staff present throughout.
5. Post-infusion Oral hydration. Energy and cognitive effects logged over the following 24–48 hours.
| Equipment | Brand / Model | Technical detail |
|---|---|---|
| IV infusion pump | B. Braun Infusomat / Baxter | Precise drip rate control in ml/h to minimise side effects. |
| Pharmaceutical-grade NAD+ | Tru Niagen / Jinfiniti / Compounding pharmacy | Pharmaceutical-grade NAD+ in saline solution. Purity control >99%. |
Clinics on LongevityMap declare their exact equipment for objective scoring.
Restore cellular energy and slow the ageing process
€180–400 per infusion
1–2 infusions/week (initial protocol: 4–6 infusions)
Prices vary by clinic, equipment and practitioner experience. LongevityMap compares price and quality so you always make the best decision.
Documented synergy between NAD+ IV Therapy and Cryotherapy. Canonical combination in literature · see protocol and evidence.
View comparison →Documented synergy between NAD+ IV Therapy and IV Therapy. Canonical combination in literature · see protocol and evidence.
View comparison →Documented synergy between NAD+ IV Therapy and Hyperbaric Chamber. Canonical combination in literature · see protocol and evidence.
View comparison →We are collecting signed consents under GDPR Art. 9.2.a. First verified testimonials will appear once the first real clinics are onboarded (Q4 2026).
Research at Harvard University (Dr. David Sinclair's lab) shows that restoring NAD+ levels activates sirtuins and the mTOR pathway, reversing epigenetic ageing markers in animal models. Clinical trials in humans (Washington University, 2018) confirm improvements in insulin resistance and muscle function with NAD+ precursor infusions. IV bioavailability is 6–10 times higher than oral.
PRISMA systematic review 2026 (113 studies, 33 in humans): oral NAD+ precursors (NR, NMN) show biochemical engagement and good tolerance; however, clinical efficacy for anti-aging remains inconclusive and no controlled trials of intravenous NAD+ for anti-aging indications exist.
Phase 2 RCT Lancet Neurology 2026 (n=66, Friedreich's ataxia): 12 weeks of nicotinamide riboside + individualised exercise significantly improved cardiopulmonary fitness (peak VO2) vs control. Combination was safe and well tolerated.
2026 crossover RCT (n=11 untrained men): oral NMN (1,200 mg/d × 7 d) suppressed muscle inflammatory signaling (TNF-α, IL-10 mRNA) after blood-flow-restriction exercise, though it also attenuated mitochondrial replenishment.
Aging Cell 2026 (mouse model): NMN + apigenin formulation increased NAD+ reserves, alleviated cellular senescence and promoted cartilage, bone and muscle regeneration in aged mice. Preclinical evidence with translational potential.
Last bibliographic review: 2026-03-28.
The infusion may cause a sensation of warmth, chest tightness, or mild nausea if administered too quickly. At quality clinics the drip rate is individually adjusted to minimise these effects. They usually resolve by slowing the rate.
Between 1.5 and 4 hours depending on the dose (typically 250–1,000 mg). Some clinics offer accelerated high-dose infusions with continuous medical supervision.
Oral NMN and NR supplements are precursors the body converts into NAD+, with limited conversion efficiency. NAD+ IV delivers the coenzyme directly to the bloodstream with maximum bioavailability.
Tell us your goal and budget. We cross-reference 500+ clinical parameters and generate 3 personalised plans with NAD+ IV Therapy.
Generate My Protocol for freeLongevityMap content is for informational and educational purposes only. It does not constitute personalised medical advice. Always consult a healthcare professional before starting any treatment. Our team · Methodology